QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ATRC

QT68AtriCure, Inc.
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
28.80
+1.68+6.19%
OverviewShort InterestFilings
ATRCQT68AtriCure, Inc.·NASDAQ
OverviewShort InterestFilings
28.80+6.19%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-0.77
Insider Own5.56%
Shs Outstand50.64M
Perf Week1.37%
Market Cap1.37BForward P/E81.70EPS next Y0.35Insider Trans0.01%Shs Float-Perf Month0.00%
Enterprise Value1.30BPEG-EPS next Q0.03Inst Own-Short Float-Perf Quarter-0.79%
Income-4806841.00P/S2.49EPS this Y104.87%Inst Trans-Short Ratio-Perf Half Y-29.89%
Sales552.15MP/B2.67EPS next Y840.00%ROA-0.71%Short Interest-Perf YTD-27.20%
Book/sh9.72P/C20.37EPS next 5Y129.48%ROE-0.95%52W High43.18 -33.30%Perf Year-11.66%
Cash/sh2.88P/FCF25.60EPS past 3/5Y-ROIC-0.34%52W Low25.36 13.56%Perf 3Y-
Dividend Est.-EV/EBITDA52.72Sales past 3/5Y17.48% 20.91%Gross Margin75.47%Volatility3.05% 2.97%Perf 5Y-
Dividend TTM-EV/Sales2.36EPS Y/Y TTM103.39%Oper. Margin-0.36%ATR (14)1.32Perf 10Y-
Dividend Ex-Date-Quick Ratio3.18Sales Y/Y TTM7.53%Profit Margin-0.83%RSI (14)55.92Recom2.00
Dividend Gr. 3/5Y-Current Ratio4.29EPS Q/Q101.57%SMA204.19%Beta0.88Target Price51.33
Payout0.00%Debt/Eq0.15Sales Q/Q13.71%SMA502.80%Rel Volume2.05Prev Close27.12
Employees1,300LT Debt/Eq0.17EarningsAug 04SMA200-13.87%Avg Volume844.30KPrice28.80
IPO DateAug 05, 2005Option/ShortYes / YesEPS/Sales Surpr.103.14% 0.71%Net Debt/EBITDA-2.88Volume1,731,528Change6.19%
Analyst Ratings
DateActionAnalystRatingTarget
May-06-26ReiteratedCanaccord GenuityBuy$53 → $55
Feb-18-26DowngradeOppenheimerOutperform → Perform$32 → $44
Feb-18-26ReiteratedCanaccord GenuityBuy$64 → $53
Feb-18-26ReiteratedUBSBuy$55
Oct-30-25ReiteratedCanaccord GenuityBuy$81 → $64
Jul-30-25ReiteratedBTIGBuy$52 → $54
Jul-31-24ReiteratedStifel NicolausBuy$30 → $26
Jul-31-24ReiteratedPiper SandlerOverweight$55 → $40
Jul-31-24ReiteratedBTIGBuy$58 → $53
May-02-24ReiteratedBTIGBuy$58
Latest News
Jun-10-26
Jun-10-2611:52AM
AtriCure, Inc. (ATRC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeekingAlpha
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue500535465
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A127137118
Gross Profit374398348
Selling, General and Administrative Excl. Other299311291
Research and Development1089096
Other Operating Expense101
Operating Income-34-3-40
Interest Expense566
Unusual Expense
———
Non-Operating Income (Expense)-61-3
Net Income Before Taxes-36-10-44
Income Taxes011
Consolidated Net Income-37-11-45
Net Income From Continuing Operations-37-11-45
Net Income-37-11-45
EPS (Recurring)-0.77-0.24-0.95
EPS (Basic, Before Extraordinaries)-0.77-0.24-0.95
EPS (Diluted)-0.77-0.24-0.95
EBITDA-916-19
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.763.55—
Gross Margin74.8074.3974.84
Operating Margin-6.80-0.56-8.60
Net Margin-7.40-2.06-9.68
Shares Outstanding484847
Market Capitalization1,3821,899—
Operating Lease Expense
———
Insider Trading Volume
$32.61$30.03$27.45$24.86$22.28● Close Price0.00K169.09K338.19K507.28K676.38KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Prange KarenDirectorMay 20 '26Sale28.653,00085,95026,373May 22 12:00 AM
Doraiswamy VinayakChief Scientific OfficerMay 15 '26Sale28.135,000140,65091,875May 18 12:00 AM
Doraiswamy VinayakChief Scientific OfficerMar 12 '26Sale29.835,000149,15096,875Mar 16 12:00 AM
WHITE ROBERT S.DirectorMar 10 '26Option Exercise14.9920,000299,800122,174Mar 12 12:00 AM
Noznesky Justin JChief Mktg & Strategy OfficerNov 26 '25Sale37.295,166192,64078,798Nov 26 12:00 AM
WEHRWEIN SVENDirectorNov 25 '25Option Exercise19.959,934198,18439,341Nov 26 12:00 AM
WEHRWEIN SVENDirectorNov 25 '25Sale38.004,967188,74634,374Nov 26 12:00 AM
WEHRWEIN SVENDirectorNov 24 '25Sale37.325,033187,83234,374Nov 26 12:00 AM
WEHRWEIN SVENDirectorNov 24 '25Option Exercise19.9510,066200,81639,407Nov 26 12:00 AM
Yuen MaggieDirectorNov 21 '25Sale35.723,000107,16011,371Nov 25 12:00 AM
Noznesky Justin JChief Mktg & Strategy OfficerSep 12 '25Sale36.303,000108,90083,964Sep 16 12:00 AM
WEHRWEIN SVENDirectorAug 22 '25Option Exercise19.9510,000199,50039,374Aug 26 12:00 AM
WEHRWEIN SVENDirectorAug 22 '25Sale37.005,000185,00034,374Aug 26 12:00 AM
WEHRWEIN SVENDirectorAug 19 '25Option Exercise19.9510,000199,50040,000Aug 21 12:00 AM
WEHRWEIN SVENDirectorAug 19 '25Sale36.005,000180,00034,374Aug 21 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR